To The Moon

Hey Tycoons! 🎩💼 Ready to embark on the adventure of a lifetime? Introducing the Tiger Tycoon Challenge – where fortunes are made, and USD 888 worth of prizes await the boldest players! 🏰🌈🎯 Objective: Build your empire, score big points, and unlock fabulous rewards!💰 Gold Rush: Grab those shiny gold coins every time you pass by it! Cha-ching! 💰💵🏠 Construct & Conquer: Step on an empty tile to construct a building to gain points! 🏰🏆 Prizes Galore: Hit the prize tile to claim your treasure – it could be anything! 🎁✨🔄 Lucky Draw: Land on the draw tile and brace yourself! You might move forward, backward, or even unlock a secret power! 🔄🔮🚀 Airdrop Alert: Keep your eyes on the sky! Periodically, the Tiger Tycoon map will rain down special rewards like stocks, vouchers, and more. Fastest finge

Hello everyone! Today I want to share some potential stocks with you! Hope it can be helpful to you!The stocks are as follow: $Amazon.com(AMZN)$ Massive bear pennant breakdown for Amazon after losing 6 months of trendline support last week.Image $Costco(COST)$ posts a double beat for the quarter! ~EPS: $4.86 vs $4.79 est ~SALES: $78.94B vs $77.96B est $Roblox Corporation(RBLX)$ worth a watch in the coming sessions... Relative Strength (+3.44% today) Bullish RSI Divergence TW Pivot Buy SignalImage $Apple(AAPL)$ Open the floodgates.Image $Micro 10-Year Yield - Oct 2023(10Y231

Welcome to review：Buffett's 10 Key Events of the Past YearWelcome to reserve the live about #2023 BRK Shareholder Meeting interpretation (Chinese) and(English) by @TBliveIn

Pharmaceutical giant Pfizer Inc. reported its first quarter 2023 results before the market on Tuesday, May 2, reporting revenue of $18.28 billion for the quarter, still beating previous estimates, despite a sharp decline in revenue related to new crowns. I. Company Profile Pfizer is an international pharmaceutical giant dedicated to the development of healthcare products, with specific businesses in pharmaceuticals, vaccines and consumer health. Second, financial analysis: the period of epidemic windfall passed, revenue and net profit dropped sharply, but better than expected On the revenue side, Pfizer's revenue for the first quarter was $18.28 billion, down 28.8% year-over-year, exceeding previous estimates of $16.6 billion. Pfizer's current revenue composition can be divided into three